期刊文献+

临床药师参与格林巴利综合征患者的药学监护实践与分析 被引量:5

Role of clinical pharmacists in the pharmaceutical care for a patient with Guillain-Barre syndrome
原文传递
导出
摘要 探讨临床药师在格林巴利综合征患者药学监护实践中的作用。通过对用药适应证及禁忌证的审核,临床药师积极参与格林巴利患者治疗策略的制定,可为临床医师提供临床合理用药治疗建议。格林巴利综合征患者应避免使用免疫原性药物,特别是外源性神经节苷脂。临床药师参与多学科治疗团队,能为药物治疗决策提供积极帮助,为患者提供合理的用药宣教,保证临床用药安全、有效、经济。 To determine the role of clinical pharmacists in pharmaceutical care for a patient with GuillainBarre syndrome,We checked the indications and contraindications of the prescriptions,and provided reasonable recommendations for clinicians.Use of immunogenic drugs,especially exogenous gangliosides,should be avoided on patients with Guillain-Barre syndrome.In the multidisciplinary team,clinical pharmacists offer for developing therapeutic strategies,to ensure safe,effective and efficient clinical medications.
作者 陈溪 贾素洁 廖音娟 古春萍 毛艳梅 肖祎云 刘芳群 CHEN Xi;JIA Su-jie;LIAO Yin-juan;GU Chun-ping;MAO Yan-mei;XIAO Yi-yun;LIU Fang-qun(Department of Pharmacy,Changsha Central Hospital,Changsha 410004;Department of Pharmacy,Third Xiangya Hospital,Central South University,Changsha 410013;Department of Pharmacy,ChangshaFourth Hospital,Changsha 410006;Department of Pharmacy,the Nanfang Hospital of Southern MedicalUniversity,Guangzhou 510515)
出处 《中南药学》 CAS 2019年第7期1141-1143,共3页 Central South Pharmacy
基金 湖南省药学会医院药学——正大天晴研究基金(No.hn2017009) 湖南省自然科学基金-科卫联合项目(No.2018JJ6132) 长沙市中心医院院内科研重点项目(No.YNKY201805)
关键词 临床药师 格林巴利综合征 神经节苷脂 药学监护 clinical pharmacist Guillain-Barre syndrome ganglioside pharmaceutical care
  • 相关文献

参考文献9

二级参考文献90

  • 1江基尧.加强我国颅脑创伤临床规范化治疗[J].中华神经外科杂志,2006,22(2):71-71. 被引量:38
  • 2江基尧.脑保护药物治疗颅脑损伤的现状与展望[J].中华创伤杂志,2006,22(4):241-242. 被引量:14
  • 3李海峰,丛志强.激素对Guillain-Barre综合征的疗效:是否存在治疗时间窗?[J].中国现代神经疾病杂志,2006,6(2):139-142. 被引量:2
  • 4中国医师协会神经外科医师分会 中国神经创伤专家委员会.中国颅脑创伤患者脑保护药物治疗指南.中华神经外科杂志,2008,24(10):723-723.
  • 5江基尧,朱诚,罗其中.现代颅脑损伤学.第2版.上海:第二军医大学出版社,2003:73-150.
  • 6Ewausquin GA, Manev H, Guidotti A, et al. Gangliosides normalize distorted single - cell intracellular free Ca^2+ dynamics after toxic dose of glutamate in cerebellar granule cells. Proc Natl Acad Sci USA, 1990, 87(20) :8017 -8023.
  • 7Sabel BA, Slavin MD. GM1 ganglioside treatment facilitates behavioral recovery from bilateral brain damage. Science, 1984, 225 (4659) :340 - 342.
  • 8Skaper SD, Leon A, Facci L. Ganglioside GM1 prevents death induced by excitatory neurotransmission in cultured hippocampalpyramidal neurons. Neurosci Lett, 1991, 126( 1 ) :98 - 101.
  • 9Skaper SD, Leon A. Monosialogangliosides, Neuroprotection, and neuronal repair processes. J Neurotrauma, 1992, 9 Suppl 2: S507 - S516.
  • 10Horman M. Efficacy and safety of ganglioside GM1 treatment in the rehabilitation of patients following closed traumatic brain injury. Results of an interim evaluation//Ledeen RW, Hogan EL, Tettamanti G, et al eds. New trends in ganglioside research: neuroehemieal and neuroregenerative aspects. Fidia research seties. 14th Ed. Padova: Liviana Press, 1988:595 -604.

共引文献308

同被引文献47

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部